Biologic Contract Manufacturing WebinarPosted on May 28, 2024 |
 |
June 6, 2024, 10:00 a.m. – 12:00 p.m. EST
Michael Hausladen, PhD, General Manager,
LOTTE Biologics
Register in advance for this meeting here.
After registering, you will receive a confirmation email.
Michael Hausladen is the General Manager for LOTTE Biologics USA, LLC, headquartered in Syracuse, NY. LOTTE Biologics is a Contract Development and Manufacturing Organization that is serving the biologic pharmaceutical market. Previous roles at Bristol Myers Squibb (BMS) included starting up the Devens, MA $350M Cell Therapy Facility, managing clinical external biologics manufacturing and various leadership roles including Director of Manufacturing and Director of Manufacturing Technology.
Prior to working in biologics, Michael worked at BMS scaling up and commercialization of enzyme catalyzed and traditional organic synthesis of active pharmaceutical ingredients. Michael has a PhD in chemical engineering from the University at Buffalo.
Other Network News
July 20, 2026Oneida Indian Nation Celebrates the Arrival of the First Phase of the $400 Million Turning Stone Evolution – Grand Opening of Luxury Hotel, The Crescent, and Fine-Dining Restaurant, SALTOneida Indian Nation leadership, elected officials and business and tourism leaders usher in a new state of luxury travel and hospitality in Upstate New York. |
July 20, 2026Oswego Health Announces New Board Leadership and Welcomes Four New Members to Board of DirectorsPeter Cullinan has been elected Chair of the Oswego Health Board of Directors. Joining him in officer roles are Katie Toomey Zaryski as Vice Chair, Ron Tascarella as Treasurer and Lynne Eggert as Secretary. |
July 15, 2026Solvay Bank Announces $50,000 to Local Non-Profit Organizations In Partnership with the Federal Home Loan Bank of New YorkSolvay Bank announced a combined $50,000 financial boost to the CNY community by awarding individual $3,125 grants to 16 area non-profit organizations distributed through the FHLBNY SBRG Program. |
